These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 28608153)
61. Flow shear stress controls the initiation of neovascularization via heparan sulfate proteoglycans within a biomimetic microfluidic model. Zhao P; Liu X; Zhang X; Wang L; Su H; Wang L; He N; Zhang D; Li Z; Kang H; Sun A; Chen Z; Zhou L; Wang M; Zhang Y; Deng X; Fan Y Lab Chip; 2021 Jan; 21(2):421-434. PubMed ID: 33351007 [TBL] [Abstract][Full Text] [Related]
62. Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis. Perruzzi CA; de Fougerolles AR; Koteliansky VE; Whelan MC; Westlin WF; Senger DR J Invest Dermatol; 2003 Jun; 120(6):1100-9. PubMed ID: 12787141 [TBL] [Abstract][Full Text] [Related]
63. Engineered mesenchymal cell-based patches as controlled VEGF delivery systems to induce extrinsic angiogenesis. Boccardo S; Gaudiello E; Melly L; Cerino G; Ricci D; Martin I; Eckstein F; Banfi A; Marsano A Acta Biomater; 2016 Sep; 42():127-135. PubMed ID: 27469308 [TBL] [Abstract][Full Text] [Related]
65. Human Ocular Angiogenesis-Inspired Vascular Models on an Injection-Molded Microfluidic Chip. Ko J; Lee Y; Lee S; Lee SR; Jeon NL Adv Healthc Mater; 2019 Aug; 8(15):e1900328. PubMed ID: 31199057 [TBL] [Abstract][Full Text] [Related]
66. Fine-tuning pro-angiogenic effects of cobalt for simultaneous enhancement of vascular endothelial growth factor secretion and implant neovascularization. Chai YC; Mendes LF; van Gastel N; Carmeliet G; Luyten FP Acta Biomater; 2018 May; 72():447-460. PubMed ID: 29626696 [TBL] [Abstract][Full Text] [Related]
67. Generation of extracellular morphogen gradients: the case for diffusion. Stapornwongkul KS; Vincent JP Nat Rev Genet; 2021 Jun; 22(6):393-411. PubMed ID: 33767424 [TBL] [Abstract][Full Text] [Related]
69. Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. Welter M; Rieger H PLoS One; 2013; 8(8):e70395. PubMed ID: 23940570 [TBL] [Abstract][Full Text] [Related]
70. Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease. Mac Gabhann F; Ji JW; Popel AS Ann Biomed Eng; 2007 Jun; 35(6):982-94. PubMed ID: 17436110 [TBL] [Abstract][Full Text] [Related]
71. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683 [TBL] [Abstract][Full Text] [Related]
72. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799 [TBL] [Abstract][Full Text] [Related]
73. Troglitazone inhibits vascular endothelial growth factor-induced angiogenic signaling via suppression of reactive oxygen species production and extracellular signal-regulated kinase phosphorylation in endothelial cells. Park BC; Thapa D; Lee JS; Park SY; Kim JA J Pharmacol Sci; 2009 Sep; 111(1):1-12. PubMed ID: 19763043 [TBL] [Abstract][Full Text] [Related]
74. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. Johnson LL; Schofield L; Donahay T; Bouchard M; Poppas A; Haubner R JACC Cardiovasc Imaging; 2008 Jul; 1(4):500-10. PubMed ID: 19198663 [TBL] [Abstract][Full Text] [Related]
75. Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Nisato RE; Hosseini G; Sirrenberg C; Butler GS; Crabbe T; Docherty AJ; Wiesner M; Murphy G; Overall CM; Goodman SL; Pepper MS Cancer Res; 2005 Oct; 65(20):9377-87. PubMed ID: 16230401 [TBL] [Abstract][Full Text] [Related]
76. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃. Lakshmikanthan S; Sobczak M; Chun C; Henschel A; Dargatz J; Ramchandran R; Chrzanowska-Wodnicka M Blood; 2011 Aug; 118(7):2015-26. PubMed ID: 21636859 [TBL] [Abstract][Full Text] [Related]
77. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway. Liu X; Zheng N; Shi YN; Yuan J; Li L J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656 [TBL] [Abstract][Full Text] [Related]
78. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber. Haessler U; Teo JC; Foretay D; Renaud P; Swartz MA Integr Biol (Camb); 2012 Apr; 4(4):401-9. PubMed ID: 22143066 [TBL] [Abstract][Full Text] [Related]
79. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]